Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

Clinical trial NCT05295628 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05295628
Sponsor: Emblok, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Aortic Valve Stenosis Aortic Valve Disease Aortic Valve Insufficiency Aortic Valve Replacement

Start date: 2023-10-17
Primary completion: 2025-05-06
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.